Literature DB >> 27786368

Comorbid autoimmune diseases in patients with sarcoidosis: A nationwide case-control study in Taiwan.

Chi-Hung Wu1,2, Pei-I Chung1,2, Chen-Yi Wu1,3, Yen-Ta Chen1,2, Yun-Wen Chiu1,2, Yun-Ting Chang1,2, Han-Nan Liu1,2,4.   

Abstract

The association between sarcoidosis and autoimmune comorbidities has been reported, however, it has seldom been confirmed by a large nationwide study. Our study aimed to clarify the association between sarcoidosis and autoimmune comorbidities in the Taiwanese. A total of 1237 patients with sarcoidosis and 4948 age- and sex-matched control subjects were selected from the National Health Insurance Research Database of Taiwan from 1997 to 2010. Multiple logistic regressions were performed to calculate the odds of comorbidities between the two groups. The prevalence of sarcoidosis was 2.17/100 000 individuals in Taiwan. Sarcoidosis patients tended to run a higher risk of autoimmune comorbidities than the control group (17.6% vs 9.4%, P < 0.05). Autoimmune thyroid disease (adjusted odd ratio [aOR], 1.32; 95% confidence interval [CI], 1.05-1.64), Sjögren's syndrome (aOR, 11.6; 95% CI, 4.36-31.0) and ankylosing spondylitis (aOR, 3.80; 95% CI, 2.42-5.97) were significantly associated with sarcoidosis. The sex-stratified analyses were carried out to demonstrate a significant association of sarcoidosis with ankylosing spondylitis in both sexes, but with autoimmune thyroid disease in male patients and with Sjögren's syndrome female patients, respectively. Besides, the diagnosis of the autoimmune comorbidities strongly associated with sarcoidosis tended to be established after that of sarcoidosis. This study demonstrated that patients with sarcoidosis tended to have autoimmune thyroid disease, Sjögren's syndrome and ankylosing spondylitis, and the diagnosis of sarcoidosis usually preceded that of associated comorbidities. Clinicians should be alert to autoimmune comorbidities in patients with sarcoidosis.
© 2016 Japanese Dermatological Association.

Entities:  

Keywords:  autoimmune diseases; comorbidity; population-based; prevalence; sarcoidosis

Mesh:

Year:  2016        PMID: 27786368     DOI: 10.1111/1346-8138.13654

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  16 in total

1.  A case of Graves' disease developing with exacerbation of sarcoidosis.

Authors:  Shinya Makino; Chisako Yagi; Mariko Naka; Sachie Hirose; Masayoshi Fujiwara; Chiho Ohbayashi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

2.  Concomitant Autoimmune Diseases in Patients With Sarcoidosis in Turkey.

Authors:  Fidan Yildiz; Şenol Kobak; Hüseyin Semİz; Mehmet Orman
Journal:  Arch Rheumatol       Date:  2020-01-08       Impact factor: 1.472

3.  Sacroiliac joint in sarcoidosis on computed tomography: a monocentric retrospective study (SISTER).

Authors:  Simon Cadiou; Guillaume Coiffier; Stéphane Jouneau; Patrick Jego; Aleth Perdriger; Nicolas Belhomme; Raphaël Guillin; Pascal Guggenbuhl
Journal:  Rheumatol Int       Date:  2021-10-12       Impact factor: 2.631

Review 4.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

5.  Association between sarcoidosis and cardiovascular Outcomes: A systematic review and Meta-analysis.

Authors:  Vikash Jaiswal; Song Peng Ang; Zouina Sarfraz; Swatika Butey; Harshwardhan Vinod Khandait; David Song; Jia Ee Chia; Dipansha Maroo; Muhammad Hanif; Mohammed Ghanim; Raja Chand; Monodeep Biswas
Journal:  Int J Cardiol Heart Vasc       Date:  2022-06-29

Review 6.  Epidemiology of sarcoidosis: current findings and future directions.

Authors:  Elizabeth V Arkema; Yvette C Cozier
Journal:  Ther Adv Chronic Dis       Date:  2018-08-24       Impact factor: 5.091

Review 7.  Sarcoidosis and Thyroid Autoimmunity.

Authors:  Piera Fazzi; Poupak Fallahi; Silvia Martina Ferrari
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-08       Impact factor: 5.555

Review 8.  Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis.

Authors:  Pleiades T Inaoka; Masato Shono; Mishio Kamada; J Luis Espinoza
Journal:  J Biomed Sci       Date:  2019-06-11       Impact factor: 8.410

9.  Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study.

Authors:  Hsin-Hua Chen; Wen-Cheng Chao; Yi-Hsing Chen; Tsu-Yi Hsieh; Kuo-Lung Lai; Yi-Ming Chen; Wei-Ting Hung; Ching-Tsai Lin; Chih-Wei Tseng; Ching-Heng Lin
Journal:  Arthritis Res Ther       Date:  2019-08-29       Impact factor: 5.156

Review 10.  Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments.

Authors:  Rashi Jain; Dhananjay Yadav; Nidhi Puranik; Randeep Guleria; Jun-O Jin
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.